Breast Cancer Clinical Trial
— EXERT-BCNOfficial title:
An EXErcise Regimen Designed to Improve Body Composition, Functional Capacity, and Strength After Treatment for Breast Cancer With Nutrition Optimization
This protocol seeks to analyze patient outcomes of the standard of care, monitored group exercise regimen of high-load resistance training and functional exercises with compound movements in conjunction with a nutrition regimen focused on food quality under close supervision on women who have been treated for breast cancer.
| Status | Recruiting |
| Enrollment | 44 |
| Est. completion date | August 20, 2024 |
| Est. primary completion date | May 20, 2024 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 20 Years to 89 Years |
| Eligibility | Inclusion Criteria: 1. Age 20-89 years 2. Women with a biopsy proven diagnosis of ductal carcinoma in situ or invasive carcinoma of the breast. 3. Women must have undergone treatment for breast cancer, including one or more of the following: surgery, radiation therapy, chemotherapy, immunotherapy, or hormonal therapy. Women undergoing active chemotherapy are not allowed on study. Treatment with targeted agents and immunotherapy is allowed. Exclusion Criteria: 1. Any current treatment with chemotherapy for breast cancer 2. Inability to get and down off the ground or squat body weight 3. Inability to safely engage in group sessions 4. Severe arthritic, joint, cardiovascular, or musculoskeletal condition deemed by PI to be unsafe to engage in resistance training |
| Country | Name | City | State |
|---|---|---|---|
| United States | AHN CI Exercise Oncology and Resiliency | Pittsburgh | Pennsylvania |
| Lead Sponsor | Collaborator |
|---|---|
| Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) |
United States,
Champ CE, Carpenter DJ, Diaz AK, Rosenberg J, Ackerson BG, Hyde PN. Resistance Training for Patients with Cancer: A Conceptual Framework for Maximizing Strength, Power, Functional Mobility, and Body Composition to Optimize Health and Outcomes. Sports Med. 2023 Jan;53(1):75-89. doi: 10.1007/s40279-022-01759-z. Epub 2022 Sep 29. — View Citation
Gardner CD, Trepanowski JF, Del Gobbo LC, Hauser ME, Rigdon J, Ioannidis JPA, Desai M, King AC. Effect of Low-Fat vs Low-Carbohydrate Diet on 12-Month Weight Loss in Overweight Adults and the Association With Genotype Pattern or Insulin Secretion: The DIETFITS Randomized Clinical Trial. JAMA. 2018 Feb 20;319(7):667-679. doi: 10.1001/jama.2018.0245. Erratum In: JAMA. 2018 Apr 3;319(13):1386. JAMA. 2018 Apr 24;319(16):1728. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Determine changes in fat mass in pounds from before to after the nutrition and exercise regimen via bioimpedance analysis | Measurement on bioimpedance analysis machine (Inbody 970) | 3 months | |
| Primary | Determine changes in fat mass in pounds from before to after the nutrition and exercise regimen via ultrasound | Measurement via ultrasound and calculation with Jackson-Pollack calculations | 3 months | |
| Secondary | Determine changes in bone mineral concentration in pounds from before to after the nutrition and exercise regimen | Measurement on bioimpedance analysis machine (Inbody 970) | 3 months | |
| Secondary | Determine changes in GAD7 anxiety score from before to after the nutrition and exercise regimen | GAD7 asks 8 questions rated from 0 to 3 | 3 months | |
| Secondary | Determine changes in PHQ9 depression score from before to after the nutrition and exercise regimen | PHQ9 asks 10 questions rated from 0 to 3 | 3 months | |
| Secondary | Determine changes in EQ-5D responses 1-5 and overall score from before to after the nutrition and exercise regimen | EQ-5D asks 5 questions rates from 1-5 and an overall rating of health | 3 months | |
| Secondary | Determine changes in strength via load measured in pounds from before to after the nutrition and exercise regimen | Load is calculated by multiplying sets by repetitions by weight lifted for a specific exercise | 3 months | |
| Secondary | Determine changes in Y-balance score for each leg | Y-balance score adds up the distance each leg can move in the front and side directions, divided by the length of the hip. This correlates inversely with fall risk. | 3 months | |
| Secondary | Determine changes in overall score of functional movement screen (FMS) from before to after the nutrition and exercise regimen | Functional movement screen (FMS) is a 7 movement test where an individual can score from 0 to 21 | 3 months | |
| Secondary | Determine changes in resting metabolic rate in kilocalories/day from before to after the nutrition and exercise regimen | Measurement via VO2 Master indirect calorimeter | 3 months | |
| Secondary | Determine changes in muscle mass in pounds from before to after the nutrition and exercise regimen | Measurement on bioimpedance analysis machine (Inbody 970) | 3 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |